CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study is studying Ruxolitinib as possible treatment for Inflammatory Breast Cancer (IBC).The Following drugs will be ...
Phase 2
Durham, North Carolina, United States and 3 other locations
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Durham, North Carolina, United States and 19 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Chapel Hill, North Carolina, United States and 27 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Chapel Hill, North Carolina, United States of America and 9 other locations
triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...
Phase 2
Durham, North Carolina, United States and 9 other locations
This research study is looking to see how well male breast cancer responds to preoperative treatment with endocrine therapy and whi ...
Phase 2
Chapel Hill, North Carolina, United States and 4 other locations
This research study is studying a combination of drugs as a possible treatment for breast cancer.The drugs involved in this study a...
Phase 2
Durham, North Carolina, United States and 16 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Chapel Hill, North Carolina, United States and 32 other locations
In this research study we are studying the effects of the combination of lapatinib plus Herceptin in subjects with breast cancer th...
Phase 2
Chapel Hill, North Carolina, United States and 8 other locations
positive (HR+) and human epidermal growth factor 2 negative (HER2-) breast cancer (BC) and other advanced solid tumors. Th...
Phase 1
Durham, North Carolina, United States and 10 other locations
Clinical trials
Research sites
Resources
Legal